Bremworth Limited/Announcement
Bremworth Limited logo

Establishment of Long-Term Incentive Plan

Insider Disclosure24 December 2020BRWConsumer Discretionary

3753309 v1





MARKET RELEASE

24 December 2020


Establishment of Cavalier Corporation Limited Long-Term Incentive Scheme


Cavalier Corporation Limited ("Cavalier") (NZX: CAV) today announces the issue of performance

rights that are convertible into ordinary shares of Cavalier to selected executive employees pursuant

to a new long-term incentive scheme ("Scheme").


The Scheme is designed to promote employee retention, further align shareholder and management

interests and reward performance that underpins the achievement of Cavalier’s business strategy

and long-term shareholder wealth creation.


Under the Scheme, the rights are convertible into shares on 1 May 2023 if, among other things, the

Company’s total shareholder return exceeds 14% per annum over the period from 1 November 2020

to 1 May 2023 (the performance period).


The number of shares that will be issued to each executive employee will depend on the extent to

which total shareholder return exceeds 14% per annum over the performance period and the price

of a Cavalier ordinary share at the time the rights are convertible into shares, save that the total

number of shares to be issued to all the executive employees would not exceed the 3% threshold in

the NZX Listing Rules.


These shares will be subject to restrictions on dealing for a two-year restriction period, as follows:

• 40% of shares will be able to be dealt with on and from the issue date;

• 30% of shares will be able to be dealt with one year from the issue date; and

• 30% of shares will be able to be dealt with two years from the issue date.


The share price at the start of the performance period is $0.3141, being the volume weighted

average sale price for a Cavalier share, calculated on all price setting trades of shares which took

place on the NZX Main Board over the 20 business days before 1 November 2020.



ENDS


For further information please contact:


George Adams

Chairman

thgadams@gmail.com

+64 21 555 040

Jackie Ellis

Media and Investor Relations

Jackie@ellisandco.co.nz

+64 27 246 2505

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • OCA — Oceania Healthcare Limited: Capital Change Notice
    2020-11-22

    Capital Change Notice Notice of grant of Share Rights under the Oceania Healthcare Limited Long Term Incentive Scheme This notice is given under the NZX Listing Rule 3.13.1 and relates to the grant of performance share rights (Share Rights) which are conve…”

  • BGP — Briscoe Group Limited: Capital Change Notice
    2021-03-17

    Terms or details of the issue Issue of Ordinary Shares under the Briscoe Group Senior Executive Incentive Plan from the Performance Rights issued on 15 April 2019. New Ordinary Shares rank pari passu with the existing fully paid Ordinary Shares on issue. Employees holding t…”

  • NZX — NZX Limited: Issue of ordinary shares and performance rights
    2021-03-14

    NZX Limited Level 1, NZX Centre 11 Cable Street PO Box 2959 Wellington 6140 New Zealand Tel +64 4 472 7599 www.nzx.com Page 1 of 2 15 March 2021 Notice of issue and lapsing of performance rights to employees of NZX Limited (NZX) This notice is given under NZX Li…”